• Substance P: Advanced Spectral Approaches and Neuroimmune In

  2026-07-22

  Explore how Substance P, a key tachykinin neuropeptide, enables next-level neuroimmune and pain research through advanced spectral analytics and robust assay strategies. Discover unique workflow innovations and cross-domain implications not found in standard guides.

• Pravastatin Sodium: Precision Tools for LDL Reduction and Ce

  2026-07-21

  Explore the advanced utility of Pravastatin sodium as a selective HMG-CoA reductase inhibitor for LDL cholesterol reduction, assay optimization, and translational research. This article reveals unique insights into transporter biology and rigorous experimental design.

• Foretinib (GSK1363089): Optimizing Multikinase Inhibition in

  2026-07-21

  Foretinib (GSK1363089) enables robust inhibition of tumor cell proliferation and metastasis across diverse preclinical cancer models, with fine-tuned protocols for both in vitro and in vivo workflows. This guide translates cutting-edge findings into actionable strategies, troubleshooting tips, and protocol enhancements for researchers pursuing ATP-competitive tyrosine kinase inhibition.

• Sodium Nitroprusside: Optimizing Nitric Oxide Donor Assays

  2026-07-20

  Sodium Nitroprusside from APExBIO enables precise control of nitric oxide signaling for vascular and platelet studies, with proven advantages in reproducibility and mechanistic clarity. This guide details best-practice workflows, experimental innovations, and troubleshooting strategies—grounded in recent sex-difference hypertension research—to help you maximize data quality in cardiovascular models.

• Sabutoclax: Pan-Bcl-2 Inhibitor for Robust Apoptosis Assays

  2026-07-20

  Sabutoclax stands out as a pan-Bcl-2 inhibitor with exceptional permeability and potency, enabling quantitative apoptosis induction in both in vitro and in vivo cancer models. This article bridges advanced protocol design, troubleshooting, and the latest innovations for maximizing Sabutoclax's translational impact.

• Applied 2'-O-Methyladenosine Workflows for RNA Modification

  2026-07-19

  2'-O-Methyladenosine stands out as a precision tool for dissecting RNA modification and purine metabolism in cell-based and analytical platforms. This guide details robust workflows, quantitative innovations, and troubleshooting strategies to ensure reproducibility and insight in nucleoside analog research.

• Thapsigargin: Gold-Standard SERCA Pump Inhibitor in ER Stres

  2026-07-18

  Thapsigargin empowers researchers to dissect calcium signaling and endoplasmic reticulum (ER) stress with unparalleled potency and reliability. Its precision as a SERCA pump inhibitor unlocks advanced workflows for apoptosis, neurodegeneration, and translational disease modeling—backed by robust data and reproducibility from APExBIO.

• Geneticin, G-418 Sulfate: Technical Guidance for Cell Select

  2026-07-17

  Geneticin, G-418 Sulfate (SKU A2513) is a high-purity aminoglycoside antibiotic essential for selecting and maintaining eukaryotic cells carrying the neomycin resistance gene. It is also used to inhibit Dengue virus serotype 2 in antiviral research. This compound is not suitable for applications requiring ethanol or DMSO solubility or where non-specific cytotoxicity is a concern.

• Gefitinib (ZD1839) for EGFR Pathway Inhibition: Advanced Wor

  2026-07-17

  Gefitinib (ZD1839) stands out as a highly selective EGFR inhibitor, enabling researchers to dissect EGFR-driven signaling and its impact on cell cycle, apoptosis, and drug resistance. This article delivers actionable protocols, troubleshooting guidance, and translational insights—bridging foundational findings with cutting-edge cancer and skin barrier research.

• Taxus chinensis Fruit Extract Suppresses Neuroinflammation v

  2026-07-16

  This study demonstrates that Taxus chinensis fruit extract (TCFE) alleviates aging-related behaviors and neuroinflammation in mice by inhibiting microglial activation through the TLR4/NF-κB/NLRP3 pathway. The findings highlight the potential of plant-derived TLR4 inhibition as a promising strategy for neuroinflammation and aging research, with detailed mechanistic and behavioral evidence supporting translational investigation.

• Metformin Hydrochloride: Expanding AMPK Modulation to Fibros

  2026-07-16

  Explore the advanced role of Metformin Hydrochloride in fibrosis and AMPK pathway modulation, with a special focus on vocal fold scarring. This cornerstone article reveals mechanistic insights and novel research applications of Metformin HCl beyond traditional metabolic models.

• Applied Use-Cases of KN-62 in Calcium Signaling and Cell Cyc

  2026-07-15

  KN-62, 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosy]-4-phenylpiperazine, stands out as a selective CaMKII inhibitor enabling precise dissection of calcium signaling, insulin secretion regulation, and cell cycle control. This guide delivers actionable protocols, troubleshooting strategies, and fresh insights—bridging advanced memory research with metabolic and cancer cell models.

• Sorafenib (BAY-43-9006): Mechanistic Leverage for Translatio

  2026-07-15

  Explore how Sorafenib (BAY-43-9006) is redefining cancer biology research by integrating deep mechanistic insights, translational strategy, and biomarker-driven approaches. This article provides protocol-ready guidance, competitive benchmarking, and a visionary outlook for researchers targeting RTK, PDGFR, and RAF/MEK/ERK signaling—anchored in recent findings on ATRX-deficient glioma sensitivity.

• HNRNPU K181 Lactylation Drives Serine Metabolic Reprogrammin

  2026-07-14

  This study identifies lysine 181 lactylation of HNRNPU as a key driver of serine metabolic reprogramming that promotes cervical cancer progression. The findings uncover a novel post-translational modification switch integrating lactate signaling with mRNA regulation, suggesting metabolic vulnerabilities for targeted intervention.

• Miltefosine Activates ERK Pathway to Reverse Leukopenia

  2026-07-14

  This study demonstrates that Miltefosine, a PI3K/Akt pathway inhibitor, also activates the Ras/MEK/ERK pathway to promote neutrophil differentiation and restore bone marrow function in leukopenia models. These findings establish a dual-pathway mechanism, offering a promising therapeutic strategy for hematological recovery.

443 records 10/30 page Previous Next First page 上5页 678910 下5页 Last page